247Wallst·2026-03-10 14:23Core Insights - Wall Street analysts are adjusting their ratings and price targets for several companies, including Novo Nordisk, Korn Ferry, Jefferies Financial Group, and Talkspace, reflecting concerns over pipeline performance, valuation compression, and acquisition outcomes [1][2]. Novo Nordisk (NVO) - TD Cowen downgraded Novo Nordisk from Buy to Hold, reducing the price target from $45 to $42, citing disappointing clinical data for CagriSema and lagging prescriptions for Ozempic [1]. - The stock is currently trading at $39.78, down 21.82% year-to-date and 53.14% over the past year, with a 52-week high of $80.53 [2]. - Despite strong Q4 2025 revenue of $45.32 billion, management has guided for a sales decline of 5% to 13% in 2026 due to pricing pressures and competition [1][2]. Korn Ferry (KFY) - Truist maintained a Buy rating on Korn Ferry but cut the price target from $88 to $75, attributing the reduction to lower industry multiples rather than fundamental concerns [1]. - The company reported Q3 FY2026 revenue of $725.04 million, up 7.2% year-over-year, and adjusted diluted EPS of $1.28, exceeding estimates [2]. - The stock is trading at $62.63, down 5.13% year-to-date, with a consensus price target of $79, indicating it is viewed as undervalued [1][2]. Jefferies Financial Group (JEF) - Morgan Stanley downgraded Jefferies from Overweight to Equal Weight, setting a price target of $49, reflecting concerns over credit and advisory softness [1]. - The stock is currently at $38.16, down 37.95% year-to-date, and has missed EPS estimates in its most recent quarter [2]. - Despite a strong FY2025 performance with investment banking net revenues up 20%, legal uncertainties related to First Brands litigation are impacting sentiment [1][2]. Talkspace (TALK) - KeyBanc downgraded Talkspace to Sector Weight from Buy following its acquisition by Universal Health Services for $5.25 per share, which removes investment upside and downside risk [1]. - The stock is trading at $5.12, reflecting a 41.05% increase year-to-date as the acquisition premium has been factored in [2]. - The company reported Q4 2025 revenue of $63.0 million, growing 29.3% year-over-year, and ended the year debt-free with approximately $93 million in cash and securities [2].